1. Home
  2. KMDA vs LND Comparison

KMDA vs LND Comparison

Compare KMDA & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • LND
  • Stock Information
  • Founded
  • KMDA 1990
  • LND 2005
  • Country
  • KMDA Israel
  • LND Brazil
  • Employees
  • KMDA N/A
  • LND N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • KMDA Health Care
  • LND Consumer Staples
  • Exchange
  • KMDA Nasdaq
  • LND Nasdaq
  • Market Cap
  • KMDA 442.1M
  • LND 375.6M
  • IPO Year
  • KMDA N/A
  • LND 2006
  • Fundamental
  • Price
  • KMDA $7.46
  • LND $3.72
  • Analyst Decision
  • KMDA Strong Buy
  • LND
  • Analyst Count
  • KMDA 2
  • LND 0
  • Target Price
  • KMDA $14.50
  • LND N/A
  • AVG Volume (30 Days)
  • KMDA 346.0K
  • LND 37.8K
  • Earning Date
  • KMDA 03-05-2025
  • LND 02-06-2025
  • Dividend Yield
  • KMDA N/A
  • LND 6.68%
  • EPS Growth
  • KMDA 124.29
  • LND 5.56
  • EPS
  • KMDA 0.27
  • LND 0.45
  • Revenue
  • KMDA $158,380,000.00
  • LND $191,133,083.00
  • Revenue This Year
  • KMDA $15.37
  • LND $55.76
  • Revenue Next Year
  • KMDA $8.58
  • LND N/A
  • P/E Ratio
  • KMDA $28.13
  • LND $8.08
  • Revenue Growth
  • KMDA 4.52
  • LND N/A
  • 52 Week Low
  • KMDA $4.74
  • LND $3.52
  • 52 Week High
  • KMDA $9.15
  • LND $5.20
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.89
  • LND 43.47
  • Support Level
  • KMDA $7.51
  • LND $3.67
  • Resistance Level
  • KMDA $8.35
  • LND $3.79
  • Average True Range (ATR)
  • KMDA 0.41
  • LND 0.07
  • MACD
  • KMDA -0.02
  • LND -0.01
  • Stochastic Oscillator
  • KMDA 33.20
  • LND 19.57

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: